Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

338 results about "Shikimic acid" patented technology

Shikimic acid, more commonly known as its anionic form shikimate, is a cyclohexene, a cyclitol and a cyclohexanecarboxylic acid. It is an important biochemical metabolite in plants and microorganisms. Its name comes from the Japanese flower shikimi (シキミ, the Japanese star anise, Illicium anisatum), from which it was first isolated in 1885 by Johan Fredrik Eykman. The elucidation of its structure was made nearly 50 years later.

Construction method of genetic engineering strain for producing shikimic acid

The invention discloses a construction method of a genetic engineering strain for producing shikimic acid. The method comprises the following steps of: 1, constructing an escherichia coli strain of which the aroA gene is knocked out; 2, constructing a recombinant expression plasmid pAR63 containing key enzyme genes aroGFBR, aroE, aroB, aroD, tktA and ppsA in the metabolic pathway of the shikimic acid, so that the genes are subjected to transcriptional control of a tryptophan promoter Ptrp; and 3, transferring the recombinant expression plasmid pAR63 into the escherichia coli strain of which the aroA gene is knocked out to obtain a production strain for expressing the shikimic acid. In the method, the aim of interrupting the metabolism of the shikimic acid is fulfilled by the knock-out of the single gene aroA, a small number of genes are knocked out, the operating difficulty is low, and the expression of the genes is in the state of starting and stopping automatically and is started automatically in the middle and late period without the induction of inducers, so the possibility of adding toxic substances into a culture medium is reduced, and the shikimic acid has high yield.
Owner:河南孟成生物药业股份有限公司

Method for improving shikimic acid volume of production with zymotechnics

A method for improving the yield of a fermentation method for producing shikimic acid pertains to the biochemical field. The invention comprises the steps that: 1) Seed culture: a lactose fermentation bacillus brevis is inoculated in a seed culture medium of pH7.0 to pH7.4, the culture is carried out in a 120 to 180rpm shake bed for 12 to 18 hours at 30 DEG C; the seed culture medium (g/L) includes: 25 to 35 parts of glucose, 15 to 25 parts of ammonium sulfate, 1.0 to 2.0 parts of potassium dihydrogen phosphate, 0.1 to 1.0 part of magnesium sulfate, 0.5 to 2.0 parts of urea, 20 to 30 parts of corn pulp and the rest of water, the pH is regulated to pH 7.0 to pH 7.4, and the sterilization is carried out for 30 minutes at 115 DEG C. 2) Fermentation culture: the seed is inoculated in a fermentation culture medium at pH7.0 to pH7.4, the inoculation amount is 5 percent, the culture is carried out in the 120 to 180rpm shake bed for 48 to 60 hours at 30 DEG C; a glyphosate inhibitor is added till the fermentation is going on for 16 to 30 hours; the fermentation culture medium (g/L) includes: 100 to 160 parts of glucose, 30 to 50 parts of ammonium sulfate, 0.5 to 2.0 parts of potassium dihydrogen phosphate, 0.1 to 1.0 part of magnesium sulfate, 20 to 30 parts of corn pulp, 30 to 50 parts of calcium carbonate and the rest of water, the pH is regulated to pH7.0 to pH7.4, and the sterilization is carried out for 30 minutes at 115 DEG C. The yield of the shikimic acid can achieve 1.667 to 2.887 times of the yield before the adding of the glyphosate, and the production is stable and reliable.
Owner:BEIJING UNIV OF CHEM TECH

Method for preparing shikimic acid extract from chromatographic waste liquor of ginkgo biloba extract

The invention discloses a method for preparing shikimic acid extract from chromatographic waste liquor of a ginkgo biloba extract. The method specifically comprises the following steps: taking waste liquor produced during preparation of the ginkgo biloba extract by macroporous resin column chromatography, and concentrating the waste liquor to the volume of 1/5 of the original volume so as to obtain pretreatment waste liquor; extracting the pretreatment waste liquor with chloroform so as to obtain an aqueous phase I; extracting the aqueous phase I with benzene to obtain an aqueous phase II; extracting the aqueous phase II with petroleum ether to obtain an aqueous phase III; diluting the aqueous phase III with water, adding a modified vermiculite adsorbent, stirring, standing, filtering andcollecting filter residues; adding water equivalent to an amount of 50 times that of the weight of the filter residues into the filter residues, performing ultrasonic treatment at a temperature of 60-80 DEG C, filtering after treatment completion, and collecting the filtrate; and performing vacuum concentration on the filtrate, and re-crystallizing, thereby obtaining the shikimic acid extract. According to the method disclosed by the invention, the shikimic acid in the waste liquor produced during preparation of the ginkgo biloba extract by the macroporous resin column chromatography can be well extracted, and the obtained product is high in quality and high in content and has wide application prospects.
Owner:YANGTZE NORMAL UNIVERSITY

Recombinant corynebacterium glutamicum capable of being used for highly yielding L-phenylalanine and application thereof

The invention discloses recombinant corynebacterium glutamicum capable of being used for highly yielding L-phenylalanine and a method for producing the L-phenylalanine (Phe) by fermentation and belongs to the field of metabolic engineering. According to the invention, a corynebacterium glutamicum engineering strain C.glutamicum19AF/99TP capable of being used for highly yielding the L-Phe is obtained in a corynebacterium glutamicum type strain ATCC13032 by carrying out induction expression on the following four genes: a 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase gene, a chorismate mutase/prephenate dehydratase gene which has resistance to feedback inhibition, a transketolase gene and a phosphoenolpyruvic acid synthetase gene. A shikimic acid metabolic pathway of an L-Phe synthetic metabolic pathway is over-expressed in the C.glutamicum ATCC13032; a key enzyme gene of a chorismic acid metabolic pathway enables the yield of the L-Phe to reach 3.47g/L; two enzyme genes which combines an expression center metabolic pathway to improve a precursor enables the highest yield of the L-Phe to reach 4.86g/L; and the original strain ATCC13032 which is used as a contrast strain cannot detect accumulation of the L-Phe in the integral fermenting process.
Owner:JIANGNAN UNIV

Method for separation and purification of shikimic acid from ginkgo biloba leaves

The invention discloses a method for separation and purification of shikimic acid from ginkgo biloba leaves, which comprises the following steps: 1, drying and smashing the ginkgo biloba leaves and refluxing and extracting through ethyl alcohol with the mass percentage being 70%, and then concentrating the mixture into a concrete shape; 2, using ultrasound to dissolve the concentrate obtained in step one in deionized water and then using petroleum ether, ethyl acetate and n-butyl alcohol to extract sequentially, and obtaining aqueous phase concrete after the aqueous phase is fully concentrated; 3, dissolving the aqueous phase concrete obtained from step two into methyl alcohol, blending with 100-200 parts of target silica gel and then drying the mixture; 4, packing the dry substance obtained in step three, eluting the substance through the mixture of ethyl acetate and methyl alcohol, gathering elution fluid, concentrating the elution fluid until the fluid is fully dry, and obtaining rough shikimic acid; 5, producing shikimic acid crystal through the recrystallization of the methyl alcohol. The method for separation and purification of shikimic acid from ginkgo biloba leaves uses ginkgo biloba leaves as the raw materials, and realizes the cyclic utilization of waste resources, having the advantages of simple extraction process and low cost; meanwhile, the shikimic acid has high production rate and purity.
Owner:贵州北极兴药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products